Hammersmith Medicines Research
20
0
0
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.0%
1 terminated/withdrawn out of 20 trials
95.0%
+8.5% vs industry average
0%
0 trials in Phase 3/4
16%
3 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Selective β2-AR Antagonism in Asthma
Role: collaborator
PET Study of Repeated ASN51 in Healthy Volunteers
Role: collaborator
A Study of Oral Ibogaine in Opioid Withdrawal
Role: collaborator
Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose
Role: collaborator
A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects
Role: collaborator
Safety, Tolerability and Pharmacokinetics of NTP42:KVA4
Role: collaborator
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects
Role: collaborator
Safety, Tolerability & Pharmacokinetics of LEVI-04 in Healthy Volunteers and Patients With Osteoarthritis Knee Pain
Role: collaborator
Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim
Role: collaborator
Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers
Role: collaborator
Comparison of Aramchol Concentrations With Once or Twice Daily Dosing
Role: collaborator
A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects
Role: collaborator
Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040b
Role: collaborator
A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607
Role: collaborator
Study Comparing Blood Levels of Fatty Acids After Consuming Two Forms of Cod Liver Oil
Role: collaborator
GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)
Role: collaborator
F901318 Multiple Ascending Dose Study
Role: collaborator
Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe
Role: collaborator
Safety, Blood Levels and Effects of MGB-BP-3
Role: collaborator
A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine
Role: collaborator
All 20 trials loaded